Showing results (1711-1720 of 1,802) with videos related to

Sort By:
Pageof 181
Nature Medicine|June 8, 2019
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanomaPaolo Antonio Ascierto, Pier Francesco Ferrucci, Rosalie Fisher, et al.
The Journal of Clinical Investigation|June 4, 2013
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growthYael Nemlich, Eyal Greenberg, Rona Ortenberg, et al.
Epilepsy & Behavior : E&B|June 15, 2013
Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)Amos D Korczyn, Steven C Schachter, Martin J Brodie, et al.
The Journal of Clinical Investigation|June 5, 2003
Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolatesHarlan D Caldwell, Heidi Wood, Debbie Crane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2013
Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapiesMichal J Besser, Ronnie Shapira-Frommer, Orit Itzhaki, et al.
The Journal of Rheumatology|October 21, 1999
A disease severity scale for systemic sclerosis: development and testingT A Medsger, A J Silman, V D Steen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
Randomized, Double-Blind, Phase III LEAP-003 Study of First-Line Lenvatinib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab for Unresectable or Metastatic MelanomaA Arance, M-A Berciano-Guerrero, J Guo, et al.
The New England Journal of Medicine|September 12, 2017
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated MelanomaGeorgina V Long, Axel Hauschild, Mario Santinami, et al.
Pharmacogenetics|August 1, 1997
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergenceP I Mackenzie, I S Owens, B Burchell, et al.
Pageof 181